Anelixis Therapeutics' Unattributed VC Round

Anelixis Therapeutics raised a round of funding on June 20, 2017. Investors include Realise Capital Partners.

Anelixis Therapeutics was formed in 2013 and is a for-profit subsidiary of ALS Therapy Development Institute (ALSTDI), a nonprofit biotechnology organization dedicated to developing effective treatmen…

Articles about Anelixis Therapeutics' Unattributed VC Round: